Bio-Rad Laboratories, Inc. (BIO)
381.76
+1.73
(+0.46%)
USD |
NYSE |
Aug 24, 16:00
381.75
-0.01
(-0.00%)
Pre-Market: 07:12
Bio-Rad Laboratories Total Liabilities (Quarterly) : 3.078B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.078B |
| March 31, 2026 | 2.939B |
| December 31, 2025 | 3.123B |
| September 30, 2025 | 2.960B |
| June 30, 2025 | 3.085B |
| March 31, 2025 | 2.848B |
| December 31, 2024 | 2.795B |
| September 30, 2024 | 3.116B |
| June 30, 2024 | 2.910B |
| March 31, 2024 | 3.559B |
| December 31, 2023 | 3.558B |
| September 30, 2023 | 3.480B |
| June 30, 2023 | 3.531B |
| March 31, 2023 | 3.904B |
| December 31, 2022 | 3.886B |
| September 30, 2022 | 3.605B |
| June 30, 2022 | 3.760B |
| March 31, 2022 | 4.191B |
| December 31, 2021 | 4.114B |
| September 30, 2021 | 4.621B |
| June 30, 2021 | 3.523B |
| March 31, 2021 | 3.324B |
| December 31, 2020 | 3.093B |
| September 30, 2020 | 3.196B |
| June 30, 2020 | 2.744B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.391B |
| December 31, 2019 | 2.254B |
| September 30, 2019 | 2.046B |
| June 30, 2019 | 2.160B |
| March 31, 2019 | 1.999B |
| December 31, 2018 | 1.591B |
| September 30, 2018 | 1.818B |
| June 30, 2018 | 1.747B |
| March 31, 2018 | 1.727B |
| December 31, 2017 | 1.343B |
| September 30, 2017 | 1.337B |
| June 30, 2017 | 1.332B |
| March 31, 2017 | 1.245B |
| December 31, 2016 | 1.327B |
| September 30, 2016 | 1.317B |
| June 30, 2016 | 1.260B |
| March 31, 2016 | 1.209B |
| December 31, 2015 | 1.219B |
| September 30, 2015 | 1.237B |
| June 30, 2015 | 1.166B |
| March 31, 2015 | 1.128B |
| December 31, 2014 | 1.156B |
| September 30, 2014 | 1.209B |
| June 30, 2014 | 1.218B |
| March 31, 2014 | 1.209B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 60.37B |
| Agilent Technologies, Inc. | 5.943B |
| Danaher Corp. | 39.78B |
| Illumina, Inc. | 3.812B |
| Revvity, Inc. | 4.817B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.25B |
| Shareholders Equity (Quarterly) | 7.174B |
| Debt to Equity Ratio | 0.191 |
| Current Ratio | 3.142 |
| Net Debt Paydown Yield | -0.00% |